Physician profile
Robert Wang
NPI 1043219876
$9,952.99
in general payments reported to CMS, 2019-2025
42 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,796 · 2020: $320 · 2021: $867 · 2022: $1,395 · 2023: $1,833 · 2024: $2,724 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,456 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,456.07 |
| Education | $119.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,134.10 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $1,056.79 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $636.45 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $614.32 | 2019-2024 | Xarelto |
| Pfizer INC. | $593.00 | 2019-2025 | |
| Abiomed | $585.39 | 2022-2025 | Impella |
| Merck Sharp & Dohme LLC | $559.57 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $489.43 | 2019-2024 | |
| Abbott Laboratories | $434.12 | 2019-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $393.45 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $368.10 | 2019-2024 | Emerge Push, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $337.97 | 2019-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $300.18 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Lexicon Pharmaceuticals, INC. | $242.75 | 2023-2024 | Inpefa |
| Shockwave Medical, INC | $233.95 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.